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Qualitative Exploration of the Experiences of Men who use Drugs of 
Obtaining Psychoactive Medicinal Products in Jordan  
Abstract: 
In Jordan, almost any medication can be bought from pharmacies. This ready availability 
is linked with abuse. Previous literature describes medicine abuse from pharmacists’ and 
general public perspectives. Here we investigate experiences of 17 men in addiction 
treatment in Amman (21-39 years) of obtaining psychoactive medicines. Alprazolam, 
clonazepam, bromazepam and tramadol were most commonly abused. Psychoactive 
medicines were obtained from street dealers, but pharmacies were preferred. Regulations 
appears ineffective; lack of understanding of pharmacists of the abuse potential of some 
medicines was perceived; ‘softening rules’ on supply was attributed to cultural and 
social norms around familiarity. 
 
 





The use of psychoactive medicinal products for non-medicinal purposes has come into 
focus in recent years (e.g. Hughes et al, 2015). There is increasing concern about deaths 
and harm associated with dependence on prescribed and over-the-counter (OTC) 
medicinal products (Cooper, 2013, Fingelton et al., 2016). This is particularly of 
prominence in the opioid crisis in the United States (NIDA, 2020). In Europe, the 
European Monitoring Center for Drugs and Drug Addiction (EMCDDA) and European 
Medicines Agency (EMA) have issued warning information around misuse of medicinal 
products, with key examples including carfentanil, pregabalin, etaqualone, zopiclone, 
aminophenylbutyric acid, gabapentin, and tropicamide (EMCDDA & Europol, 2013; 
EMCDDA, 2014). 
 
Individual countries implement various methods of regulation and control of 
public access to medicinal products. The access status of a chemical compound (the 
‘raw’ medicine) or medicinal product (the compound formulated in a product for use) 
varies between countries. The extent to which systems are in place to enforce regulatory 
frameworks also varies. In Jordan, drug classification and laws controlling supply are 
similar to those in Europe and the United States. Medicines are supplied against a 
prescription or sold OTC in community pharmacies; other retail outlets such as 
supermarkets do not sell medicines. Controlled drugs, including opioids and opioid 
derivatives are classified into eight schedules. Non-opioids that have been scheduled in 
recent years include alprazolam in 2013 and pregabalin in 2017 (JFDA, 2012, JFDA, 
2017a). According to the Narcotic Drugs and Psychotropic Substances Law, pharmacists 
are required to keep records of scheduled drugs to be checked by JFDA inspectors 
(JFDA, 2019). Therefore, community pharmacists may be unlikely to sell such products 
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without prescription, especially higher scheduled drugs which are more tightly 
controlled. However, for medicinal products outside of these schedules, it is common for 
them to be sold from pharmacies without prescription. These include most 
benzodiazepines and barbiturates, for which no written record of supply is required. In 
the Middle East, the political situation, security issues and closure of borders had led to 
shortages of illicit drug supplies. This had led people who use drugs to seek alternatives.  
Examples include ophthalmic drugs, used to disguise red eyes from cannabis smoking or 
are sometimes ingested in high amounts to experience high, (Al-Khalaileh, et al., 2018), 
pregabalin used to augment opioids or alone for sedation or anxiety (Al-Husseini et al., 
2018) and oral hypoglycemic agents, usedto induce euphoria or the so-called 
“hypoglycemic rush”, (Wazaify et al., 2019). The practice of selling prescription 
medicines without prescription may reflect pharmacists seeing themselves traditionally 
in a prescribing role, as they tended to have, prior to stricter medicines laws. The lack of 
systems within the Jordanian Food and Drugs Administration (JFDA) to enforce more 
strictly medicines regulation is also a factor (Al-Wazaify et al., 2005; Yousef et al., 
2008). This lack of regulatory enforcement is not unique to Jordan, it is common to other 
areas in the region (Jousilahti et al., 1997; Matowe et al., 2003; Sweileh et al., 2004). 
The situation however likely compounds the potential for harm from prescription and 
OTC medicines, including the development or sustainment of harmful consumption, 
which can facilitate dependence.  
Previous research in Jordan found that 100% (n=290) of pharmacists who 
completed a self-reported questionnaire suspected that some level of non-medicinal use 
of medicinal products occurred amongst patients of their pharmacy (Wazaify et al., 
2017). The pharmacists named 156 different products as suspected of being abused, with 
an average of 4.9 per pharmacist (range = 1–9 products reported per pharmacist) The 
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psychoactive therapeutic classes most commonly implicated were decongestants, other 
cough and cold preparations and benzodiazepines. Pharmacists reported several methods 
to limit customers' access to suspected products, most commonly sale refusal and stating 
that the product was not available (31.0%, n= 90). Insisting on having a valid 
prescription for dispensing (n=43, 14.8%) was also used. Eighty-eight pharmacists 
(30.3%) reported that they advised the patients on the harms of inappropriate use, but 11 
(3.8%) pharmacists reported that they did nothing and supplied the product(s) requested. 
Female pharmacists were more reluctant to ‘provide advice’ (24% vs. 34%, p = 0.037), 
and more likely to ‘do nothing’ (12% vs. 6%, p = 0.041) than males. This study, 
although potentially limited by recall bias and restriction to two Jordanian cities, gives 
insight into the beliefs and practices of community pharmacists in Jordan with regard to 
medicinal product misuse. Findings suggest there is scope to develop the pharmacists’ 
role in responding to OTC and prescription misuse of medicines, for example by 
developing practice guidance on ways they can respond to suspected dependence. 
However, there is to date nothing in the literature to describe the other side of the story, 
that is the lived experiences of people in Jordan who use medicinal products for non-
medicinal purposes. It is important to understand their experience of obtaining such 
products. Such a study would provide insight into access to medicinal products from the 
users’ perspective, which in turn could inform the development of effective practice 
measures to control availability, support pharmacists’ practice and advice to patients. 
Before and after study built around regulation change could also explore the impact of 
that regulation change from the perspective of users. 
 
Aim 
This study aims to describe the lived experiences of people in treatment for drug 
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dependence in obtaining prescribed or OTC psychoactive medicines in Jordan, prior to 
the rescheduling of alprazolam. The discussion presented here has a focus on the role of 
pharmacists and the impact of the regulatory systems on drug sources and availability. 
Methods 
Study Design 
This study took a qualitative approach, using semi-structured, audio-recorded interviews. 
This approach was taken to capture the experiences of participants who were dependent 
on prescribed or OTC medicines in obtaining their drugs, often in excessive quantities. 
The interviews followed a pre-designed semi structured interview guide, prepared by 
MW and JS, based on previous work and our knowledge of prescription and OTC 
medicine dependence literature from Jordan. JS has prior experience of qualitative 
research. Where judged appropriate, probes were used to explore points raised in more 
depth. 
Subjects and Setting 
Participants were recruited through the Addiction Treatment Center (ATC) in Amman, 
Autumn 2013 prior to the rescheduling of alprazolam. MW had prior professional 
knowledge of this center. The ATC provides short term residential detoxification and 
rehabilitation typically over a two to four-week period. The use of a gatekeeper was 
essential, with permission to access residents granted by the head of the center. Potential 
participants were identified by the head and deputy. All participants who met the 
inclusion criteria were provided with a written Participant Information Sheet which 
explained the study. It also explained that MW was from the University of Jordan and 
independent of their care. MW attended the center on subsequent days. Potential 
participants were then invited to opt into the study. There were no rewards for 
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participation or penalties for refusal. Data recordings and anonymized transcripts were 
kept confidential to the research team. 
 
Inclusion criteria 
• Eighteen years of age or older. 
• Capacity to consent to participation in research as judged by persons involved in 
the provision of care at the Addiction Treatment Center. 
• Experience of non-medicinal use of prescribed or OTC medicines in Jordan. 
Interview process, data recording and storage 
The interviews were conducted by the lead author (MW), in a private room within the 
Addiction Treatment Center, with only the interviewer and the participant present, 
except for the first interview where the center head sat in. Prior to the interview, the 
researcher sought written consent and permission to record the interview. Confidentiality 
and anonymity in reporting was assured. It was made clear that the participant could stop 
the interview at any time. In such cases they would be asked if the data recorded so far 
could be kept for use or whether they wished it to be destroyed. It was also made clear 
the participant could withdraw from the study for one week after their participation, 
prior to data being built into the analysis. No one withdrew. Interviews were conducted 
in Arabic then processed as described below. 
 
After completion of the interview the participant was debriefed by MW. This 
was to ensure any distress or issues that raised concerns during the interview were 
addressed. The participant was thanked for their time and participation. Figure 1 below 




[Insert Figure 1: Summary of the flow of the study participants] 
Ethics 
The study was approved by the Institutional Review Board, Jordan University Hospital 
(JUH) and two Scientific Research Committees: at the Faculty of Pharmacy and Deanship 
of Academic Research (DAR) at University of Jordan. 
 
Data Analysis 
Interviews were transcribed verbatim in Arabic, checked for accuracy and stored as 
Microsoft Word files. All files were anonymized and assigned a code number. 
Transcription and translation into English language were done by the same researcher 
who conducted the interviews (MW). Another bi-lingual researcher (NA) compared all 
translated English scripts with the original Arabic ones. A third independent bilingual 
researcher not involved in the study back translated one transcript to validate accuracy of 
transcribing. Analysis was undertaken by NA and JS, with input in interpretation from 
MW. English language transcripts were read then reread to familiarize the analysts with 
the raw data. They were then imported into NVivo (v10 & 12) software. Thematic 
analysis was undertaken and comprised three stages. Stage one identified statements of 
interest that related to the aim, grouping them under key headings (codes). Codes were 
derived both inductively from the data and deductively from prior knowledge and 
literature. NA and JS both coded five transcripts to check for agreement. NA coded the 
rest. Stage two reduced these initial codes (axial coding), to refine them, bringing 
together related initial codes under second level sub-themes. Stage three further refined 
these by comparing axial codes, interpreting and condensing them where appropriate to 
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overarching themes. Deviant case analysis was also undertaken, so relevant codes that 
did not ‘fit’ with the emerging themes were used to identify isolated experiences and 
beliefs. Themes were agreed between NA and JS and then discussed with MW. Quotes 




A convenience sample of seventeen participants were interviewed. It is unknown how 
many were initially approached. The Center typically has about 30 residents at any one 
time, although not all may have met the inclusion criteria. Average length of stay at the 
Center prior to interview was 10 days (range 5 – 14 days), suggesting those in an acute 
withdrawal phase were unlikely to have been included. Interviews lasted between 10 and 
44 minutes (median 16 minutes). All were male. There are no female resident facilities 
at the Addiction Treatment Center. Median age was 27.5 (range 21 to 39 years). All 
reported dependence on one or more prescription or over the counter medicine. 
Alprazolam, clonazepam, bromazepam and tramadol were the most commonly used 
drugs. Most but not all participants used such drugs in combination with illicit drugs 
(e.g. heroin, Captagon (fenethylline) or hashish) to augment or modify effects. 
 
Overarching themes 
Participants described experiences of obtaining medicines from three main sources: drug 




Obtaining medicines from street dealers 
Drug dealers were reported to be a source of prescription medicines, sometimes 
alongside the purchase of illicit substances such as heroin. Some participants compared 
the perceived quality of medicines obtained from dealers with those they had obtained 
from pharmacists. They perceived there to be a risk of obtaining counterfeited or low-
quality products from dealers. Some felt the quality from pharmacy to be higher and 
cited this as their reason for pharmacies being their preferred source. This dialogue with 
participant 9 illustrates: 
Participant 9: I had to buy from people I knew and I started being introduced [to 
others]. I mean, these [people] would introduce me to a pharmacist, and here to 
[another] pharmacist. So, I started preferring to buy from pharmacies better than those 
[dealers] who sell. 
 
Researcher:  Why? 
 
Participant 9: Because, if you'd excuse my saying, they [dealers] would bring things that 
are not fit…[pharmacy stock is]..not cheated [referring to quality and content] 
 
Researcher: Counterfeited. What's in the pharmacy is not ..? 
 
Patient: Not counterfeited 
 
The riskiness of interacting with dealers, in terms of violence and associated ‘trouble’ 
that the person could find themselves in was also highlighted as a reason to prefer to 




Some participants knew their dealers were supplied by pharmacists who sold in large 
bulk quantities without a prescription. This is illustrated by participant 2:   
It is known that they [pharmacists] sell it to one or two persons. And those 
persons sell it to us in higher prices even if they [pharmacists] didn’t sell it to us they sell 
it to other people and they sell it to us. You know the black market. 
 
Moreover, some participants reported preferring to buy from the pharmacist rather than 
dealers since the latter’s price is more expensive. 
Participant 13: I used to pay JD10 for the pharmacist [to buy Prazin, which normally 
cost JD8] 
Researcher: Not much more than the normal price 
Particiupant 13: No..no..because guys [dealers] who sell outside of pharmacy sell the 1 
tablet for JD1, that is JD 30 for one packet. 
 
Obtaining prescription/OTC medicines from pharmacies 
There were two sub themes which distinguished different mechanisms of obtaining 
medicines from pharmacies for non-medical use, with several intersecting factors under 
each theme, as described. 
(i) Buying medicines without providing a valid prescription 
It was common for participants to have obtained OTC/prescription medicines from 
pharmacists without a valid prescription. Some reported having an invalid prescription 
that had previously been spent, but having further supplies facilitated by the pharmacist 
against this spent prescription or against knowledge of this prior spent prescription 
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having existed. Pharmacists were seen to sometimes intentionally or accidentally not 
stamp prescriptions to invalidate them. Participants believed this was so the prescription 
could knowingly be used again or because they were being ‘lazy’ or ‘going soft’ (see 
below). Others reported no prescription of any kind being involved in the transaction. 
 
Researcher: Now you used to go and buy two of the drugs from the pharmacy, the 
Prazin [alprazolam] and the Revotril [clonazepam] …… with a prescription or without?’ 
 
Participant 13: Without… 
 
Researcher: He never asked you for a prescription? 
 
Participant 13: Not once…without any resistance, he used to give me with total comfort 
 
The participants perceived there to be several reasons as to why a pharmacist would give 
medicines without a valid prescription, including financial motives, going ‘soft’ on 
regulations and the abuse profile of the medicine being seen as low: Financial motives 
‘Greed’ -  It was perceived that in some cases, pharmacists may sell ‘abusable’ drugs as 
an extra source of income. It was reported that this is done by selling the medicine pack 
at a higher price than it would be sold to legitimate patients. Participant 9 explains: 
I used to buy it [Prazin (alprazolam)] for 25 JD's… 5 times more…Then I started 
taking Saliba [clonazepam].  The Saliba pack, I think, used to cost 4 JD's, here too I 




Another way reported to persuade the pharmacist to sell medicines without a valid 
prescription is to buy large quantities at a time: 
Researcher: Why did he [pharmacist] used to give you the drug without a prescription? 
Participant 7: Because I bought from him .. nearly 10 thousand JD’s [worth]. 
 
Pharmacists ‘going soft’ on the regulations - Some pharmacists were seen to ‘go soft’ on 
the regulations. Participants reported they knew a prescription is required every time 
someone buys a prescription medicine, but that pharmacist might ask for a prescription 
only once in a while, especially when the pharmacist knew the person had previously 
been in receipt of a prescription for the medicine. 
 
Researcher: Did you used to buy [the drug] with a prescription most of the time? 
Participant 11: Yeah, from amongst the times, yeah….I mean, the pharmacist used to 
know me, yeah 
Researcher: So even without a prescription he used to give you [the drug]? 
Participant 11: Sometimes 
 
 
Another way of ‘going soft’ on the regulation is selling the ‘abusable’ medicine 
repeatedly against the same prescription. Whilst regulations require the pharmacist to 
stamp and return, or retain the prescription, the pharmacist was said to sometimes leave 
it with the patient to use it again, unstamped: As participant 7 describes, ‘…. so I kept 
buying the medicine on the same prescription.’  
Familiarity was a factor perceived to influence the pharmacist to ‘go soft’ on the 
regulations. Personal relationships between the participant and the pharmacist were 
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perceived to create a social pressure where the pharmacist found it hard to refuse to sell 
to acquaintances. 
I used to bring him prescription for Remeron [mirtazapine], Respal [risperidone], 
and Stedon [diazepam] since a long time ago, and we became friends I mean, he 
[pharmacist] started giving me [medicines] without a prescription. Participant 7. 
Participants described unfamiliar pharmacists more likely to adhere to the regulations. 
Abuse profile of the drug seen to be low - It was perceived by participants that the abuse 
potential may not always be commonly known, so the medicines were not tightly 
controlled by the pharmacist. Participant 8 explained: 
At the beginning I used to get it from a pharmacy, in a comfortable way, without any 
medical prescription. 
 
Interviewer: Without any prescription? 
 
Participant 8:  [It was] normal, without a prescription. But not now, not now, not in 
these times…This medicines’ status was very normal, because not many people knew 
about it, not many used to take it………….Do you know what I mean? Then little by little 
by little by little, pharmacists realized that this drug is asked for in more-than-normal 
quantities. So, they researched it and found that it contained a narcotic substance 
 
In contrast to this, one participant reported a pharmacist refusing to dispense a 
medication because it had abuse potential, but their decision was overruled by the 
prescriber. Participant 17 explains:  
The second week after my endoscopy, I saw the doctor and he asked ‘So, how are 
you [name]?’ I replied that I had a heartburn. He said: ‘No way! With the Xanax?!!!’ I 
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said: ‘I didn’t get the Xanax as the pharmacist said it may cause dependence’. The 
doctor got angry and said ‘What!!! The pharmacist does not know better than me. Here 
is another prescription [for Xanax]. I am your doctor, I know what is best for you. Don’t 
listen to the pharmacist’….I went to the pharmacist, didn’t find Xanax but got Prazin 
[the generic] and then started my problem, I started to escalate the dose gradually, tried 
to stop more than once 
 
(ii) Buying prescription/OTC medicines from pharmacists via a valid 
prescription 
 
Poor practices from other health care professionals were also reported by participants. 
On some occasions, doctors wrote prescriptions for patients knowing or suspecting that 
they were using them for non-medical purposes. The perceived reasons participants 
believed this was done were similar to beliefs held about pharmacists: financial gain, 
inadequate regulation and friendship between the doctor and the patient. With regard to 
financial motives, some participants reported some private doctors having ‘a price’ at 
which they would supply valid prescriptions for medicines for non-medical purposes. 
Participant 7 describes:  
Then there was a private doctor in Amman, I thought I would put my mind at rest 
and pay 25 JD’s every month and take it at my leisure, [this would be] better than going 
from one pharmacy to another. 
Changes in regulation where control was tightened were noted to influence prescribing 
practice in some cases, as illustrated by participant 8:  
It’s [tramadol] prepared from opium, I mean, and it’s addictive. So, it was 
[available] through a medical prescription only, so we turned to doctors to get medical 
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prescriptions from them. The doctor used to write it to me with much ease and get it to 
me [too]. They [regulations] tightened it on doctors, they tightened it on pharmacists, so 
it became more difficult for us to obtain it from a pharmacy. 
 The influence of familiarity and friendship was again noted in this context, against the 
lack of confirmation of diagnosis or appropriateness of the medication: Participant 14, 
who was a nurse, obtained prescriptions through colleagues:  
Yeah. Let me tell you something, it becomes like fellowship...he believes me….the 
pharmacist didn’t have a main role [in this case]….the physicians did, they didn’t ask 
for proof. 
Nagging and insistence were reported to be used by some participants to obtain the 
prescription they wanted. This dialogue with participant 7 highlights: 
Researcher: Did no one [doctor] try to refuse your request? To say, no, I don’t want to 
prescribe you this, I’m worried you might become addicted, did no one ever [say]? 
Participant 7: Yeah, this doctor, not the [name] one, the other one, used to say this, ‘you 
shouldn’t take these, these are not for your case’, I didn’t listen to him, I said ‘no, I want 
them’  
Researcher: You kept insisting until he wrote you a prescription? 
Patient: Yeah, I kept insisting 
 
Obtaining medicines from hospitals illegally 
Some participants reported getting their abused drug from hospitals. In one situation, the 
participant was a healthcare professional who became addicted to pethidine. He 
(participant 14) describes that he used to collect the dose by taking some from each 
ampoule he was instructed to administer to patients: ‘There would be a patient, we’d 
sometimes prescribe him 100 [mg], I’d give him 75 and hide 25, yeah…a prescription 
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and another prescription, until I take the full dose’. Although the regulations in Jordan 
indicate that two members of hospital staff should witness the administration of drugs 
scheduled like pethidine, ‘softening’ of this regulation, by staff themselves, was noted 
by this participant as enabling him to divert the pethidine ‘This never used to happen 
[witnessed administration]… It was an issue of trust”. 
 
As noted with regard to doctors and pharmacists in the community, familiarity and 
friendship were again given as a reason to circumvent or relax regulations in the hospital 
context. Participant 8 explains to the researcher how his uncle facilitated his access to 
tramadol injections: 
Researcher: ‘Tramal injections? Where do you get them from? 
 
Participant: From [private hospital name]. My uncle was a nurse at [hospital name], you 
know, he ought to have looked into [it], and..and, for example, when they receive an 
accident, God forbid, they would immediately prescribe medicines and it would all be 
covered by the insurance company, okay. For example, he’d register it with the accident 
because there is no supervision over him, there is no supervision over him. Do you know 
what I mean? That’s all, there is no one to keep an eye on, okay, it was registered on a 
certain accident’s record, who administered it? this dose went to this accident?  am sure 
no one follows. In our country we have so many [accidents]. 
 
Discussion 
This is the first paper, to our knowledge, that has described the experiences of people 
from Jordan in obtaining medicinal products for non-medicinal psychoactive purposes. 
We found medicinal products used alongside illicit drugs and on their own. The data, 
17 
 
which was collected just before alprazolam was scheduled as a controlled substance (in 
2013), illustrates its popularity as a medicine of abuse at that time. The paper highlights 
a preference for obtaining medicines from healthcare sources due to the likelihood of 
counterfeit medicines being sold by street dealers. Dealer-sold medicines gave concerns 
over both quality and safety. Participants appeared to trust pharmacists to sell genuine 
products. The paper also reports lower price to be a motivator to obtain medicines from 
pharmacists, although others reported inflated prices and ‘greed’ from pharmacists, 
because the purchaser was known or suspected to be dependent. We describe how the 
lack of enforcement of regulations around psychoactive medicines appears to facilitate 
purchase or access for non-medicinal use. Pharmacists and doctors were said to ‘bend 
the rules’ or ‘go soft’ around medicines regulation. This reflects the findings of Al-
Husseini et al, (2018) who observed sales of pregabalin in community pharmacies. They 
found that 57.1% (n=44) of the observed sales of pregabalin (n=77) across 14 
pharmacies in three months in 2016/17, were conducted without prescription, despite a 
prescription being required by regulation. The legitimate provision of medicines in 
Jordan is undertaken as a private transaction, there is no national health service/state 
reimbursement. This means patients pay for the cost of their medicines to the 
pharmacist, including a mark-up for dispensing. Pharmacies in Jordan run as private 
businesses. Many are independent businesses, not part of large chains, although chain 
pharmacies do exist. (Abu Asab et al., 2019). In this setting, pharmacists have to run a 
successful trade to keep the pharmacy open and make profit. Pharmacists sometimes 
receive incentives from manufacturers to sell medicines, a practice which happens in 
Jordan. In 2017, there were attempts to stop non-prescription pregabalin sales by the 
JFDA, by announcing that they would not grant incentives on quantities sold. Despite 
this, pregabalin products continued to be sold without a prescription and without fear of 
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legal accountability, until it was scheduled in December 2017 (JFDA, 2017a). Inspectors 
from the JFDA visit community pharmacies to check any violation in general and check 
prescriptions for medicines, such as opioids, opioid derivatives, or opioid containing 
preparations classified as Schedules 1–8 drugs (Jordan Pharmaceutical Association, 
2013). The pharmacist is required to keep a record of these scheduled prescriptions and 
supply against them, for JFDA inspection. Thus, it is reported by the JFDA to be rare for 
a community pharmacist to sell schedule 1-8 products (JFDA, 2017c). The pregabalin 
case illustrates how pharmacist behavior was perceived to have been modified by legal 
rescheduling of the substance but not by removing financial incentives. However, the 
medicines used for psychoactive effects by our participants were mostly substances not 
subject to scheduling at the time of this work, except our participants reported tramadol 
use, which was scheduled in 2000. Stricter legal scheduling may promote behavior 
change in pharmacists non-prescription selling activity, but this needs further explored 
against the conflicting other motivators such as profit, social and cultural context (see 
below). A follow up study to investigate the impact of pregabalin and alprazolam 
scheduling from the perspective of people who abuse prescription/OTC medicines is 
advocated. 
Many participants were not clear on the reasons why pharmacists they knew 
might intermittently request a valid prescription (enforce the rules). It was seen as 
practice that was ‘in between’ sale without a valid prescription and refusal to supply 
anything ‘abusable’. This practice requires more exploration, but it may be explained by 
social and cultural contexts. It is common practice for many (non-psychoactive) 
prescription medicines to be sold without prescription in Jordan, antibiotics being one 
example (Haddadin et al, 2019). It could be looked on as bad customer service or 
awkward to ask the patient to bring a prescription every time they want a pack of a 
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medicine that they are perceived to require, having had a previous valid diagnosis, as 
indicated by the past prescription. Such requests mean the patient has to go to the doctor 
and spend time and money on a consultation to obtain a prescription (Hammad et al, 
2018). The pharmacist may feel this is an unnecessary expense or that the patient may 
not return with the prescription to their pharmacy, so they lose the sale. Another possible 
explanation is that some pharmacists may request intermittent prescriptions, as they feel 
this might protect themselves against the authorities, should they conduct any checks, 
suggesting a conflict between obeying rules and profit making. 
Considering the ethical responsibility of the pharmacist to do no harm, in Jordan, the 
responsibility of getting addicted is culturally seen to lie with the patients themselves 
(Wazaify et al., 2017). This may explain the apparent disregard reported from some 
pharmacists of the potential for dependence, which threads through some of the 
participant accounts. Placing the cultural lens of individual responsibility as a sole 
reason for addiction over the reported actions of the pharmacist, modifies the impression 
one gets of the pharmacist’s perceived implication in the person’s addiction. Social 
pressure, especially in the Middle-Eastern region, may also play an important role in 
explaining why some pharmacists may not want to refuse sale. Pharmacists, like others, 
may feel the obligation and desire to help an acquaintance or regular patient with their 
needs, despite holding concerns around dependence (Wazaify and Scott, 2017). 
Education of pharmacists on the dependence potential of medicines should also be 
explored further as a way to promote behavior change. Postgraduate education in Jordan 
is left to the individual with no mandatory requirement for ongoing license to practice. 
We suggest that the JFDA consider exploring mechanisms for manufacturers of 
medicines liable to misuse to finance independent education for pharmacists on these 
risks and ways to support dependent persons with treatment and detoxification. 
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Our findings show relaxation of the rules by doctors and hospital healthcare 
professionals might also be due to social and cultural norms between healthcare 
professionals and the lack of adherence to rules as familiar practice becomes ‘slack’. For 
example, JFDA instructions to nurses responsible for administration of narcotics and 
psychotropic drugs, item#8 states ‘in case of using parts of the dose of the syringe, the 
remaining drug should not be kept in the syringe as it will be liable to pollution. Rather, 
it should be discarded and witnessed by the physician who should sign and date that on 
the prescription’ (JFDA, 2007). Clearly, our participant accounts illustrate relaxation of 
adherence to this guidance. 
 
Limitations of the study 
This study relied on gatekeepers to facilitate access to participants (the ATC manager 
and his deputy). It is possible that some patients may have been excluded due to 
selection biases. We did not formally collect information on people invited to take part 
who declined, however only two patients declined and did not state a reason. Some 
interviews were quite short, explained by their focus on a narrow topic and the extent to 
which some participants were willing to discuss issues. The richness of such short 
interview data was limited. Women were not represented in our sample because there 
was no capacity to treat women at ATC. For the first interview, the ATC head sat in, 
which may have limited or biased discussion in this one case. Data was collected in 
2013, so the time gap must be acknowledged. However, there is no other literature of 
this kind from Jordan and its collection before the scheduling of alprazolam and 
pregabalin allows for pre-scheduling reporting. Future study could provide follow up 






This study is the first to explore the experiences of people in treatment for addiction in 
Jordan on obtaining psychoactive medicines for non-medicinal purposes. This paper has 
highlighted the role pharmacists and doctors play, knowingly or unknowingly, in the 
supply of psychoactive medicines for non-medicinal purposes in Jordan. It illustrates 
how the regulations as they were at the time, appeared not to control access to these 
medicines. The tightening of regulations would require greater level of inspection of 
pharmacies and greater application of regulator controls. We also identified a perceived 
lack of understanding by pharmacists of the misuse potential of some medicines sold. 
This highlights the importance of including this in the curriculum of pharmacy 
undergraduate education, and for postgraduate education, so pharmacists can be better 
informed of the risks and ways to reduce them. 
 
The cultural and social norms of familiarity allow for softening of the rules across 
healthcare professionals (e.g. nurses, doctors and pharmacists). This is likely to have an 
intersectional relationship with the (low) risk of penalty through inspection and regulator 
sanctions, alongside personal responsibility being seen a key factor in dependence. This 
warrants further investigation. Consideration should be given to inclusion of these issues 
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